BCT-19418-24559
2 vaccinations
4 coded responses
30 check-ins
4 free-text entries
2 call cases
- Sex
- Male
- Age at first dose
- 26-30
- ZIP prefix
- 926 / CA
- Registered
- 2021-03-25
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-25
Registered in v-safe
-
2021-03-25
Dose 1 — Janssen/Johnson & Johnson
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-08
- 2021-04-15
- 2021-04-22
- 2021-04-29
- 2021-05-06
- 2021-06-24
-
2021-09-23
Survey response — 6 months, dose 1MedDRA: Medical counselling, Office visit, Vertigo positional — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Symptoms: Was diagnosed with BPPV · Healthcare visit (other): I did a phone consultation and an in-person consultantion with an ENT doctor who quickly told me it was bppv. The whole meeting lasted no longer than 10 minutes. Never had bppv beforeMedDRA releases: 2024-11 · check-in free text available
-
2021-09-23
Report sent to call center — 6 months, dose 1Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-09-30
-
2021-09-30
Call successfulParticipant prefers to complete VAERS report online
-
2021-11-30
Dose 2 — Moderna
- 2021-11-30
-
2021-12-01
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-12-02
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache · Be unable to work or attend schoolAdult check-in
- 2021-12-03
- 2021-12-04
-
2021-12-05
Survey response — days 1–6 daily, dose 2MedDRA: Pharyngeal swelling, Swelling — Feeling: GoodFree text: Mild Swollen throat/neckMedDRA releases: 2024-11 · check-in free text available
- 2021-12-07
-
2021-12-14
Survey response — day 14, dose 2MedDRA: Chest pain, Dyspnoea, Fatigue, Heart rate increased, Office visit — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: High resting heart rate, chest pain/ache, shortness of breath, fatigue · Healthcare visit (other): Appointment with cardiologistMedDRA releases: 2024-11 · check-in free text available
-
2021-12-14
Report sent to call center — day 14, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2021-12-15
-
2021-12-15
Call successfulParticipant prefers to complete VAERS report online
- 2021-12-21
-
2021-12-28
Survey response — day 28, dose 2MedDRA: Hyperacusis, Migraine, Photophobia — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Migraine with sensitivity to light and sound. Never had a migraine in my lifeMedDRA releases: 2024-11 · check-in free text available
- 2022-01-04
- 2022-01-11
- 2022-03-01
- 2022-06-02
- 2022-11-30
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Janssen/Johnson & Johnson | |
| 2 | 2021-11-30 | Moderna | No |
Call center
2 call center cases
2 successful
Free text
Release 9 — 6 months, dose 1
Symptoms: Was diagnosed with BPPV
Healthcare visit (other): I did a phone consultation and an in-person consultantion with an ENT doctor who quickly told me it was bppv. The whole meeting lasted no longer than 10 minutes. Never had bppv before
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Mild Swollen throat/neck
Release 10 — day 14, dose 2
Symptoms: High resting heart rate, chest pain/ache, shortness of breath, fatigue
Healthcare visit (other): Appointment with cardiologist
Release 10 — day 28, dose 2
Symptoms: Migraine with sensitivity to light and sound. Never had a migraine in my life
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| HCVO | Office visit | · | · | ✓ |
| HCVO | Vertigo positional | · | · | ✓ |
| SD | Chest pain | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Heart rate increased | · | · | ✓ |
| SD | Hyperacusis | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Photophobia | · | · | ✓ |
| SD | Vertigo positional | · | · | ✓ |
| SRO | Pharyngeal swelling | · | · | ✓ |
| SRO | Swelling | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release